What did Remedy Meds pay for Thirty Madison, Inc.?

Remedy Meds acquired Thirty Madison, Inc. for $500.0M in 2025, equivalent to 2.30x revenue. Target revenue was approximately $220.0M.

What does Thirty Madison, Inc. do?

Thirty Madison, Inc. is a healthcare it business.

What multiple did Remedy Meds pay for Thirty Madison, Inc.?

2.30x revenue, based on disclosed deal value of $500.0M and disclosed financials.

M&A TRANSACTION · 2025

Thirty Madison, Inc. acquired by Remedy Meds

$500.0M· 2.30x revenue

Target

Thirty Madison, Inc.

Acquirer

Remedy Meds

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$220.0M

EBITDA

—

Deal Value

$500.0M

EV/EBITDA

—

Context

This $500.0M acquisition of Thirty Madison, Inc. by Remedy Meds sits in the healthcare it sub-vertical. Remedy Meds is acquiring as a strategic buyer; see how strategic acquirers typically price healthcare it businesses on our Healthcare It strategic buyer-pool page.

Source

Data sourced from Press release. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own healthcare it

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Thirty Madison, Inc. acquisition.

Citation: ExitValue.ai. (2025). Thirty Madison, Inc. acquired by Remedy Meds. https://exitvalue.ai/deals/thirty-madison-inc-acquired-by-remedy-meds-hc-2025-0006